NYSE: LCTX - Lineage Cell Therapeutics, Inc.
Доходность за полгода: -3.54%
Сектор: Healthcare
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-11.08 | 61.13 | -118.13% | 0 | 0% |
P/E Forward 
|
|
-10.25 | 0 | 0% | ||
| P/S |
|
26.76 | 4.09 | 554.15% | 112.1 | -76.12% |
| P/S Forward |
|
29.81 | 112.1 | -73.41% | ||
| P/BV |
|
41.79 | 9.64 | 333.64% | 2.78 | 1402.82% |
| P/BV Forward |
|
72.42 | 2.78 | 2504.4% | ||
| Ev/Ebitda |
|
-6.49 | 17.28 | -137.53% | -6.72 | -3.46% |
| Ev/Ebitda Forward |
|
-6.49 | -6.72 | -3.46% |
